Cited 18 times in
In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김강표 | - |
dc.contributor.author | 김준원 | - |
dc.contributor.author | 박광우 | - |
dc.contributor.author | 안성귀 | - |
dc.contributor.author | 이익재 | - |
dc.contributor.author | 정준 | - |
dc.contributor.author | 최진현 | - |
dc.date.accessioned | 2018-07-20T07:52:38Z | - |
dc.date.available | 2018-07-20T07:52:38Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 2234-1900 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/160619 | - |
dc.description.abstract | PURPOSE: To report the results of a correlation analysis of skin dose assessed by in vivo dosimetry and the incidence of acute toxicity. This is a phase 2 trial evaluating the feasibility of intraoperative radiotherapy (IORT) as a boost for breast cancer patients. MATERIALS AND METHODS: Eligible patients were treated with IORT of 20 Gy followed by whole breast irradiation (WBI) of 46 Gy. A total of 55 patients with a minimum follow-up of 1 month after WBI were evaluated. Optically stimulated luminescence dosimeter (OSLD) detected radiation dose delivered to the skin during IORT. Acute toxicity was recorded according to the Common Terminology Criteria for Adverse Events v4.0. Clinical parameters were correlated with seroma formation and maximum skin dose. RESULTS: Median follow-up after IORT was 25.9 weeks (range, 12.7 to 50.3 weeks). Prior to WBI, only one patient developed acute toxicity. Following WBI, 30 patients experienced grade 1 skin toxicity and three patients had grade 2 skin toxicity. Skin dose during IORT exceeded 5 Gy in two patients: with grade 2 complications around the surgical scar in one patient who received 8.42 Gy. Breast volume on preoperative images (p = 0.001), ratio of applicator diameter and breast volume (p = 0.002), and distance between skin and tumor (p = 0.003) showed significant correlations with maximum skin dose. CONCLUSIONS: IORT as a boost was well-tolerated among Korean women without severe acute complication. In vivo dosimetry with OSLD can help ensure safe delivery of IORT as a boost. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Society for Therapeutic Radiology and Oncology | - |
dc.relation.isPartOf | RADIATION ONCOLOGY JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Radiation Oncology | - |
dc.contributor.googleauthor | Jason Joon Bock Lee | - |
dc.contributor.googleauthor | Jinhyun Choi | - |
dc.contributor.googleauthor | Sung Gwe Ahn | - |
dc.contributor.googleauthor | Joon Jeong | - |
dc.contributor.googleauthor | Ik Jae Lee | - |
dc.contributor.googleauthor | Kwangwoo Park | - |
dc.contributor.googleauthor | Kangpyo Kim | - |
dc.contributor.googleauthor | Jun Won Kim | - |
dc.identifier.doi | 10.3857/roj.2017.00150 | - |
dc.contributor.localId | A05299 | - |
dc.contributor.localId | A00958 | - |
dc.contributor.localId | A01432 | - |
dc.contributor.localId | A02231 | - |
dc.contributor.localId | A03055 | - |
dc.contributor.localId | A03727 | - |
dc.contributor.localId | A04697 | - |
dc.relation.journalcode | J02592 | - |
dc.identifier.eissn | 2234-3164 | - |
dc.identifier.pmid | 28712278 | - |
dc.subject.keyword | Boost with intraoperative radiotherapy | - |
dc.subject.keyword | In vivo dosimetry | - |
dc.subject.keyword | Segmental mastectomy | - |
dc.subject.keyword | Toxicity | - |
dc.contributor.alternativeName | Kim, Kangpyo | - |
dc.contributor.alternativeName | Kim, Jun Won | - |
dc.contributor.alternativeName | Park, Kwang Woo | - |
dc.contributor.alternativeName | Ahn, Sung Gwe | - |
dc.contributor.alternativeName | Lee, Ik Jae | - |
dc.contributor.alternativeName | Jeong, Joon | - |
dc.contributor.alternativeName | Choi, Jinhyun | - |
dc.contributor.affiliatedAuthor | Kim, Kangpyo | - |
dc.contributor.affiliatedAuthor | Kim, Jun Won | - |
dc.contributor.affiliatedAuthor | Park, Kwang Woo | - |
dc.contributor.affiliatedAuthor | Ahn, Sung Gwe | - |
dc.contributor.affiliatedAuthor | Lee, Ik Jae | - |
dc.contributor.affiliatedAuthor | Jeong, Joon | - |
dc.contributor.affiliatedAuthor | Choi, Jinhyun | - |
dc.citation.volume | 35 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 121 | - |
dc.citation.endPage | 128 | - |
dc.identifier.bibliographicCitation | RADIATION ONCOLOGY JOURNAL, Vol.35(2) : 121-128, 2017 | - |
dc.identifier.rimsid | 40776 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.